Medirom Healthcare Technologies Inc (MRM)

MEDIROM Healthcare Technologies Inc. is a Japan-based healthcare and wellness company whose common stock is represented in the U.S. by an ADR listed on NASDAQ. Through its subsidiaries, the company provides holistic health services across three operating segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. Its relaxation salon business develops, operates, franchises, and supports salons under the Re.Ra.Ku and Ruam Ruam brands, offering bodywork, stretching, posture and joint alignment services, and related therapies. The digital preventative healthcare segment includes the government-sponsored Specific Health Guidance program, the Lav smartphone application, and the MOTHER Bracelet, along with preventive services supported by nutritionists and health nurses. The luxury beauty segment operates hair salons under the ZACC brand. MEDIROM also runs Re.Ra.Ku College, which provides training for franchise owners and salon personnel. The company was incorporated in 2000 and is headquartered in Tokyo, Japan.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-MRM
$0.86
11.6% Upside
Fair
Not available
Not available
Weak
0.0%
23.0x
3.8x
0.1x
6.085 M
37.235 M
76.3%
72.9%
-2.4
-2,389.4%
Valuation • Fair Value

Medirom Healthcare Technologies Inc (NASDAQ-MRM) Fair Value by Valuation Model

Review the available estimates for Medirom Healthcare Technologies Inc (NASDAQ-MRM), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.86

Estimated upside of 11.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.62

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.36

Classic Ben Graham valuation formula reference.

Comps Fair Value

$1.02

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Medirom Healthcare Technologies Inc (NASDAQ-MRM) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Medirom Healthcare Technologies Inc (NASDAQ-MRM)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

56.011 M

Current operating scale indicator.

Revenue Forecast

57.249 M

Forward revenue estimate.

EBITDA

1.035 M

Current operating profitability reference.

EBITDA Forecast

2.862 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Medirom Healthcare Technologies Inc (NASDAQ-MRM) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Medirom Healthcare Technologies Inc (NASDAQ-MRM)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-0.62

Higher caution zone on this screen.

Altman Z-Score

-2.4

Lower score that deserves closer risk review.

FCF / Net Income

-2,389.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Medirom Healthcare Technologies Inc (NASDAQ-MRM). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Medirom Healthcare Technologies Inc (NASDAQ-MRM)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Medirom Healthcare Technologies Inc (NASDAQ-MRM). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Medirom Healthcare Technologies Inc (NASDAQ-MRM) Stock Forecast & Technical Outlook

Review Medirom Healthcare Technologies Inc (NASDAQ-MRM) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Medirom Healthcare Technologies Inc (NASDAQ-MRM)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Medirom Healthcare Technologies Inc (NASDAQ-MRM) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Medirom Healthcare Technologies Inc (NASDAQ-MRM) Stock FAQ

Data-supported answers about Medirom Healthcare Technologies Inc (NASDAQ-MRM), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.86
Estimated upside 11.6%
Valuation Rating
Undervalued
Estimated upside of 11.6%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is $0.86. This implies an estimated upside of 11.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 11.6% versus the current market price.

The current financial health read for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Medirom Healthcare Technologies Inc (NASDAQ-MRM).

The current P/E ratio listed for Medirom Healthcare Technologies Inc (NASDAQ-MRM) is 23.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Medirom Healthcare Technologies Inc is 6.085 M.

The current enterprise value listed for Medirom Healthcare Technologies Inc is 37.235 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Medirom Healthcare Technologies Inc is NASDAQ-MRM, and the stock is listed on NASDAQ.

Medirom Healthcare Technologies Inc (NASDAQ-MRM) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Medirom Healthcare Technologies Inc is 76.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Medirom Healthcare Technologies Inc is 72.9%. Free float helps investors understand how much of the share base is available for public trading.